Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Nov / Time to Rethink Race-based Research?
Biochemistry and molecular biology Guidelines and Recommendations

Time to Rethink Race-based Research?

Biomedical researchers should change the way they use race and ethnicity in research, says report

By Helen Bristow 11/19/2024 News 2 min read

Share

A new report from the National Academies of Sciences, Engineering, and Medicine calls on biomedical researchers to evaluate the merits of including race to define cohorts on a case by case basis. It also advises transparency and justification for categorizing research participants by race or ethnicity.

Typically, biomedical studies in the US collect patient data in accordance with the US Office of Management and Budget (OMB) categories for race. This has led to a trend to stratify results by race, despite decades of research that disproves the biological basis of race. Observations of a higher incidence of sickle cell disease among Black patients, for example, have subsequently been attributed to geographic distribution or ancestry rather than race.

Arguing that race and ethnicity do not account for genetic variation or determine the likelihood and course of disease, the consensus report expresses concern that they are still used in biomedical research. It suggests that social factors such as racism and poverty, that may have a greater impact on health, have been neglected as a result.

Despite this, the report does acknowledge that race and ethnicity attributes can be useful in certain circumstances – such as ensuring a diverse or representative cohort of participants. If researchers do decide to capture race and ethnicity in their work, they are encouraged to define those terms in all reports and state the rationale for their inclusion. But what should guide those decisions?

The report suggests some considerations:

  • Appropriateness – Researchers should consider the historical and social context of their research question, and consider the benefits, limitations, and/or harms of using race and ethnicity. They should refrain from making unsupported inferences, such as relying on race and ethnicity as causes of biomedical outcomes in individuals.

  • Transparency – Researchers should assess and report the performance of biotechnologies across a range of racial and ethnic groups

  • Rationale – All inclusions or exclusions of racial and ethnic categories should be based on scientific rationale, motivated by the research question.

  • Definition – Researchers should explain their approach to using race and ethnicity, including any limitations. 

  • Measures – Multiple measures of economic and social factors should be included, where possible. Researchers should not rely solely on data that asks people to self-identify their race based on race and ethnicity categories.

The National Academies hopes that the recommendations in this report will help to ensure responsible use of race and ethnicity in research and an end to the harm that their misuse can cause. If adopted, this new approach has the potential to reduce bias in research and health care, engendering greater trust among patient groups and communities.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Microbiology and climate change: Building a sustainable future together
Guidelines and Recommendations
Microbiology and climate change: Building a sustainable future together

January 27, 2022

1 min read

Serum Rhubarb Please… Stat!
Guidelines and Recommendations
Serum Rhubarb Please… Stat!

February 25, 2022

10 min read

We must weigh the benefits and risks of every test we perform – our patients’ lives hang in the balance

The Need for Nuance in a Polarizing Pandemic
Guidelines and Recommendations
The Need for Nuance in a Polarizing Pandemic

July 27, 2022

4 min read

From politics to pandemic fatigue, the long road from 2020 came with a series of hurdles that stopped an effective response in its tracks

IVDR Compliance: A Marathon, Not a Sprint
Guidelines and Recommendations
IVDR Compliance: A Marathon, Not a Sprint

September 13, 2022

3 min read

Reaching the IVDR compliance finishing line requires significant time and resources – but it’s an investment that will pay off in spades

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.